[144] VERACYTE, INC. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Veracyte, Inc. (VCYT) reporting a proposed sale of 2,283 common shares, with an aggregate market value of $75,864.09, scheduled approximately for 09/19/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The shares were acquired as restricted stock units on 06/02/2025 from the issuer and were fully issued on that date. The filer certifies there are no undisclosed material adverse facts and reports no other sales by the same person in the past three months. The filing provides basic transactional details but does not state the seller's identity or motivation for the sale.

Positive

• Transparent regulatory disclosure of a proposed sale under Rule 144, providing market participants with transaction details
• Sale involves RSUs issued by the company, indicating proceeds arise from compensation, not an external disposition

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider notice for a small block of RSU-derived shares; unlikely to be material to VCYT valuation.

The Form 144 states a proposed sale of 2,283 shares valued at $75,864.09, representing a very small fraction of the 78,671,588 outstanding shares. The shares were issued as restricted stock units on 06/02/2025 and the sale is to be executed through a major broker on NASDAQ. This is a standard disclosure under Rule 144 enabling a market sale by an affiliate; absent additional context (seller identity, pattern of sales, or size relative to holdings), the filing appears informational rather than market-moving.

Corporate Governance Expert

TL;DR: Compliance-focused filing that documents a planned sale of recently vested RSUs; disclosure aligns with regulatory requirements.

The notice documents acquisition via RSUs and the intended sale mechanism, fulfilling the filer’s obligation to disclose proposed sales under Rule 144. The statement that no material non-public information is known and the absence of prior sales in the past three months are typical compliance elements. For governance review, the filing raises no immediate red flags but lacks identity of the selling affiliate, which is common in Form 144 summary tables.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2283	75864.09	78671588	09/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/02/2025	Restricted Stock Units	Issuer			2283	06/02/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for VCYT report?

The filing reports a proposed sale of 2,283 common shares of Veracyte (VCYT) valued at $75,864.09, to be sold approximately on 09/19/2025 on NASDAQ.

How and when were the VCYT shares being sold acquired?

The shares were acquired as restricted stock units (RSUs) from the issuer on 06/02/2025 and were fully issued on that date.

Through which broker will the VCYT shares be sold?

The sale is to be executed through Morgan Stanley Smith Barney LLC, based on the broker information in the filing.

Does the Form 144 show other sales by the same person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

How large is the proposed sale compared with VCYT's outstanding shares?

The proposed sale of 2,283 shares is noted alongside 78,671,588 shares outstanding, indicating the transaction is a very small fraction of total shares outstanding.